Innoviva Inc Earnings

The next earnings date for Innoviva Inc is November 5, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Innoviva Inc Earnings

Report DateEstimated Earnings Per Share
11/05/2025$0.40

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Innoviva Inc Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
07/30/2025---$0-100.00%
05/06/2025Before Market$-0.74---
02/26/2025Before Market$0.26-36.59%
11/04/2024Before Market$0.02-92.31%
07/31/2024After Market$-0.55-329.17%
05/08/2024After Market$0.46170.59%
02/29/2024After Market$0.76230.43%
11/01/2023After Market$0.98262.96%
08/02/2023After Market$0.02-92.31%
05/09/2023After Market$0.4282.61%
02/28/2023After Market$-0.98-526.09%
11/09/2022After Market$2.8025.00%
07/27/2022After Market$0.05-97.41%
04/27/2022After Market$0.35-20.45%
02/09/2022After Market$0.14-65.85%
10/27/2021After Market$0.90109.30%
07/28/2021After Market$0.90210.34%
04/28/2021After Market$0.848,500.00%
02/03/2021After Market$0.4820.00%
10/28/2020After Market$0.26-38.10%
07/29/2020After Market$0.69115.63%
04/29/2020After Market$0.5963.89%
02/05/2020After Market$0.42-16.00%
10/30/2019After Market$0.36-2.70%
07/24/2019After Market$0.34-20.93%
05/01/2019After Market$0.31-13.89%
02/06/2019After Market$0.60-7.69%
10/31/2018After Market$0.43-12.24%
07/26/2018After Market$0.49-10.91%
04/26/2018Before Market$0.27-49.06%
02/08/2018After Market$0.5019.05%
10/25/2017After Market$0.22-29.03%
07/26/2017After Market$0.3011.11%
04/27/2017After Market$0.18-33.33%
02/09/2017After Market$0.2215.79%
10/27/2016After Market$0.13-31.58%
07/28/2016After Market$0.138.33%
04/28/2016After Market$0.04-60.00%
02/03/2016After Market$0.04300.00%
10/28/2015After Market$-0.04-33.33%
07/29/2015After Market$-0.07-16.67%
05/06/2015After Market$-0.09-12.50%
02/18/2015After Market$-0.140.00%
10/30/2014After Market$-0.19-26.67%
08/06/2014---$-0.57-29.55%
05/07/2014---$-0.62-16.98%
02/06/2014---$-0.46-21.05%
10/24/2013---$-0.4444.30%
07/25/2013---$-0.3719.57%
04/25/2013---$-0.380.00%
02/12/2013---$-0.3319.51%
10/30/2012---$-0.375.13%
07/31/2012---$-0.422.33%
04/26/2012---$0.9310.71%
02/09/2012---$-0.45-15.38%
10/27/2011---$-0.37-12.12%
07/28/2011---$-0.31-10.71%
04/28/2011---$-0.280.00%
02/15/2011---$-0.2510.71%
10/21/2010---$-0.29-7.41%
07/22/2010---$-0.280.00%
04/21/2010---$-0.35-20.69%
02/11/2010---$-0.35-6.06%
10/27/2009---$-0.35-2.94%
07/23/2009---$-0.350.00%
04/22/2009---$-0.313.13%
02/12/2009---$-0.2627.78%
10/23/2008---$-0.342.86%
07/24/2008---$-0.4410.20%
04/21/2008---$-0.49-2.08%
02/14/2008---$-0.541.82%
10/25/2007---$-0.5315.87%
07/26/2007---$-0.75-10.29%
04/26/2007---$-0.82-22.39%
02/08/2007---$-0.631.56%
10/26/2006---$-0.630.00%
07/27/2006---$-0.706.67%
04/27/2006---$-0.86-24.64%
02/09/2006---$-0.79-12.86%
10/27/2005---$-0.71-18.33%
07/27/2005---$-0.601.64%
05/04/2005---$-0.59-5.36%
02/16/2005---$-0.56-24.44%

More About Innoviva Inc

Website
https://www.inva.com
Country
USA
Full Time Employees
127

Innoviva, Inc. engages in the development and commercialization of pharmaceutical products in the United States and internationally. The company's products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist (LAMA) and umeclidinium bromide (UMEC) with a LABA, VI; GIAPREZA (angiotensin II), a vasoconstrictor to increase blood pressure in adults with septic or other distributive shock; XERAVA (eravacycline), a tetracycline class antibacterial for the treatment of complicated intra-abdominal infections in adults; XACDURO, a beta lactamase inhibitor for the treatment of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia; and ZEVTERA, a cephalosporin antibacterial for the treatment of adult patients with staphylococcus aureus bloodstream infections, adult patients with acute bacterial skin and skin structure infections, and adult and pediatric patients with community-acquired bacterial pneumonia. Its development pipeline includes Zoliflodacin, a late-stage product candidate, a potential single oral dose cure for the treatment of uncomplicated gonorrhea. Innoviva, Inc. has a strategic partnership with Sarissa Capital Management LP. It has long-acting beta2 agonist (LABA) collaboration agreement with Glaxo Group Limited to develop and commercialize once-daily products for the treatment of chronic obstructive pulmonary disease and asthma. The company was formerly known as Theravance, Inc. and changed its name to Innoviva, Inc. in January 2016. Innoviva, Inc. was incorporated in 1996 and is headquartered in Burlingame, California.

“Innoviva Inc Earnings” Can Refer to the Innoviva Inc Earnings Date

Some people say “Innoviva Inc earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Innoviva Inc position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Innoviva Inc Stock on the Earnings Date

If you own Innoviva Inc stock (INVA) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Innoviva Inc might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Innoviva Inc shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Innoviva Inc Earnings

You can contact us any time if you would like to ask questions about Innoviva Inc earnings or anything else related to the stock market.

This site uses cookies to provide you with an optimal user experience. By using StockMarketGuides.com, you accept our use of cookies.